l General Information |
Product Name | Pranlukast hemihydrate |
General description | Pranlukast is a subtype specific CysLT1 receptor antagonist. |
Synonym | 8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran |
Purity | ≥98.0%(HPLC) | CAS Number | 150821-03-7 |
Formula | C27H23N5O4 · 0.5H2O | Molecular Weight | 490.51 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White Solid |
Solubility(25℃) | DMSO | ≥10mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Proinflammatory agent. Stimulates c-Fos and c-Jun proto-oncogene transcription in human monocytes. Stimulates chemotaxis, aggregation, and degranulation of polymorphonuclear leukocytes. |
l Storage |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
